Gut-Brain Axis Therapeutics, Inc.
PrivateLast Round
Series A
Nov 6, 2025
Total Funding Raised
$6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Gut-Brain Axis Therapeutics, Inc. is a biotechnology company that develops microbiota transplant therapies aimed at treating gastrointestinal disorders and symptoms associated with autism and Pitt-Hopkins syndrome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gut-Brain Axis Therapeutics, Inc. Comparables
Compare Gut-Brain Axis Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Holobiome | 81% | |
| Bloom Science | 78% | |
| Genome & Company | 78% | |
Gut-Brain Axis Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 6, 2025 | ||||
| Seed | Dec 20, 2024 |
Gut-Brain Axis Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HealthTech Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 14, 2026
Grew 400% QoQ from 1 to 5 employees.
- Nov 6, 2025
$20M round completed.
Gut-Brain Axis Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Gut-Brain Axis Therapeutics, Inc.'s valuation, stock price, and market status.